Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H20N2O2 |
Molecular Weight | 236.3101 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCC(O)CN1CCN(CC1)C2=CC=CC=C2
InChI
InChIKey=PTVWPYVOOKLBCG-UHFFFAOYSA-N
InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2
Molecular Formula | C13H20N2O2 |
Molecular Weight | 236.3101 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1295724Curator's Comment: Description was created based on several sources, including
https://www.epharmapedia.com/medicine/profile/193457/Troferit.html?lang=en&tab=druginfo
https://www.ncbi.nlm.nih.gov/pubmed/7649341
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1295724
Curator's Comment: Description was created based on several sources, including
https://www.epharmapedia.com/medicine/profile/193457/Troferit.html?lang=en&tab=druginfo
https://www.ncbi.nlm.nih.gov/pubmed/7649341
Dropropizine is a cough suppressant. It has peripheral action in non-productive cough. Dropropizine is commercialized in Latin American and African countries.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Antitussive activity of the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae). | 2003 |
|
Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry. | 2003 Dec 25 |
|
Antitussive effect of diltiazem in experimental conditions. | 2004 |
|
Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry. | 2004 Aug |
|
The influence of animal species on the relationship between ATP-sensitive potassium ion channels and defense reflexes of the airways. | 2009 |
|
Sensitive spectrophotometric method for quantitation of guaifenesin and dropropizine in their dosage forms. | 2010 |
Patents
Sample Use Guides
In Vivo Use Guide
Curator's Comment: can also be used rectally http://www.ndrugs.com/?s=troferit
30 mg 6 or 8 hourly
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3081798
When the Chinese hamster V79 cells were treated with the highest concentration of Dropropizine (8000 ug/ml), cytostatic effects lasting
24 h were observed
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:11:04 GMT 2023
by
admin
on
Sat Dec 16 17:11:04 GMT 2023
|
Record UNII |
U0K8WHL37U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29698
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
||
|
WHO-VATC |
QR05DB19
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
||
|
WHO-ATC |
R05DB19
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DROPROPIZINE
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
m4770
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | Merck Index | ||
|
2332
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
SUB06412MIG
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
967
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
757820
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
23419
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | RxNorm | ||
|
3169
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
C73179
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
100000092095
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
241-683-7
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
DTXSID0045624
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
U0K8WHL37U
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
117067-01-3
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
SUPERSEDED | |||
|
C035916
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
DB13785
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
17692-31-8
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY | |||
|
CHEMBL151445
Created by
admin on Sat Dec 16 17:11:04 GMT 2023 , Edited by admin on Sat Dec 16 17:11:04 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |